Advair hfa 115 21?

What is Advair HFA 115/21?

Advair HFA 115/21 is a medication that combines two active ingredients: fluticasone propionate, an inhaled corticosteroid (ICS), and salmeterol xinafoate, a long-acting beta2-adrenergic receptor agonist (LABA) [1]. It is designed to treat asthma and chronic obstructive pulmonary disease (COPD) in adults and children as young as six years old.

How does Advair HFA 115/21 work?

The combination of fluticasone and salmeterol works together to reduce inflammation and open up the airways, making it easier to breathe. Fluticasone propionate helps to decrease airway inflammation and swelling, while salmeterol xinafoate helps to relax the airway muscles and open them up for proper breathing.

How is Advair HFA 115/21 administered?

The medication comes in an inhaler that users must prime before use. To use the inhaler, users must take one puff twice daily, in the morning and evening, while standing upright with their mouth and nose away from the inhaler.

Is Advair HFA 115/21 available in generic form?

Advair HFA 115/21 is a branded medication, but generics have become available. According to DrugPatentWatch.com [2], the patent for Advair HFA 115/21 expired in the United States in July 2021, allowing generic manufacturers to produce the medication.

What are potential side effects of Advair HFA 115/21?

Like all medications, Advair HFA 115/21 can cause side effects. Users should be aware of symptoms such as:

* Headache
* Throat irritation
* Mouth and throat inflammation
* Hives
* Worsening of asthma symptoms
* Increased risk of pneumonia

What are common patient concerns about Advair HFA 115/21?

Some users may be concerned about potential interactions with other medications, allergic reactions, or the impact of long-term use of the medication on lung health.

Patent Expiration and Generic Availability

Advair HFA 115/21's patent expired on May 24, 2021, according to DrugPatentWatch.com [2]. As a result, generic versions of the medication are now available, which could increase competition and lower prices.

References

[1] [https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a8ca8c1-b0a3-4e1b-89c7-5b5d3f0c0a5f]

[2] [DrugPatentWatch.com] (2021). Advair HFA 115/21 Patent Expiration Date.